MENU
VOR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Vor Biopharma (VOR) Ownership - Who owns Vor Biopharma?
Vor Biopharma Inc is a clinical stage cell therapy company... Show more
Profile
Industry
N/A
Address
100 Cambridgepark Drive
Phone
+1 617 655-6580
Employees
168
Web
https://www.vorbio.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
244.5M
P/E Ratio
N/A
Total Cash
200.57M
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
3.59
Dividend Yield
N/A
Total Cash/Share
1.58
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
VOR
Capitalization
244M
P/E Ratio
N/A
Risk (Beta)
3.59
Dividend Yield
N/A
Total Cash
201M
Total Cash/Share
1.58
Total Debt
0
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
-1.51B
P/B Ratio
3.14
Cash Flow
N/A
Earnings
-13.68
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
13K
Current Ratio
3.49
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-362.82M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-959.44
Shares Held By Institutions
52M
Shares Outstanding - Current
127M
Total Liabilities
1.71B
Total Volume MTD
N/A
Value
1
Gain YTD
73.874
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. VOR showed earnings on August 07, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
100 Cambridgepark Drive
Phone
+1 617 655-6580
Employees
168
Web
https://www.vorbio.com